Dermatology - Clinical Pharmacology News & Articles

401 Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis A Bayesian Network Meta-analysis Ustekinumab vs Other Biological Agents for Psoriasis JAMA Dermatology, December 18, 2012    Evidence Based Medicine    Clinical Article

402 Top-Accessed Article: Successful Treatment of Vitiligo With 0.1% Tacrolimus Ointment JAMA Dermatology, December 18, 2012    Clinical Article

403 Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports Cancer Investigation, December 18, 2012

404 Bevacizumab-Induced Oral Mucositis in Background of Cutaneous Plaque-Type Psoriasis Annals of Pharmacotherapy, December 17, 2012    Clinical Article

405 Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sezary syndrome Leukemia and Lymphoma, December 17, 2012

406 Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma JAMA Dermatology, December 14, 2012    Clinical Article

407 Successful Treatment of Bullous Pemphigoid With Omalizumab Treatment of Bullous Pemphigoid With Omalizumab JAMA Dermatology, December 14, 2012    Clinical Article

408 Acute interstitial nephritis and drug rash with secondary to Linezolid Full Text Indian Journal of Nephrology, December 14, 2012

409 Diphencyprone immunotherapy for viral warts in immunosuppressed patients British Journal of Dermatology, December 11, 2012

410 Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus The Journal of Dermatology, December 10, 2012

411 Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement The Journal of Dermatology, December 10, 2012

412 Efficacy of ustekinumab in refractary palmoplantar pustular psoriasis British Journal of Dermatology, December 7, 2012    Clinical Article

413 Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis The Journal of Dermatology, December 7, 2012    Clinical Article

414 Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia Dermatologic Therapy, December 6, 2012    Clinical Article

415 Antibiogram testing of pediatric skin infections in the era of methicillin-resistant Staphylococci aureus: an Egyptian University Hospital-based study International Journal of Dermatology, December 6, 2012    Clinical Article

416 Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii Mycoses, December 5, 2012

417 Nitroglycerin: A Review of Its Use in the Treatment of Vascular Occlusion After Soft Tissue Augmentation Dermatologic Surgery, December 4, 2012    Clinical Article

418 Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt European Journal of Pediatrics, November 29, 2012    Clinical Article

419 Long-Term Results for IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines Dermatologic Surgery, November 28, 2012    Clinical Article

420 Efficacy of a Tyrothricin-Containing Wound Gel in an Abrasive Wound Model for Superficial Wounds Skin Pharmacology and Physiology, November 28, 2012

1 Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study Journal of the European Academy of Dermatology and Venereology, April 29, 2013

2 Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline Australasian Journal of Dermatology, February 22, 2013

3 A randomized, double-blind, placebo and active-controlled, half-head study to evaluate the effects of platelet rich plasma on alopecia areata British Journal of Dermatology, April 23, 2013

4 Amiodarone and the risk of cancer Cancer, April 18, 2013

5 Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options Annals of Pharmacotherapy, April 9, 2013

6 Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses JAMA Dermatology, March 25, 2013

7 Serum prolidase activity in psoriasis patients Archives of Dermatological Research, April 10, 2013

8 Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion Arthritis Research & Therapy, April 19, 2013

9 A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment Indian Journal of Dermatology, April 22, 2013    Free full text

10 Pimecrolimus for psoriasis Expert Opinion on Pharmacotherapy, April 8, 2013

11 Combined use of botulinum toxin type A and B for forehead rhytides: a randomized, double-blind, split-face study Journal of Dermatological Treatment , April 4, 2013

12 Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University Journal of the American Academy of Dermatology, February 25, 2013

13 Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study Journal of Dermatological Treatment , April 5, 2013

14 Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis Clinical, Cosmetic and Investigational Dermatology, March 15, 2013    Free full text

15 Rapid relief of intertrigo-associated pruritus due to Candida albicans with isoconazole nitrate and diflucortolone valerate combination therapy Mycoses, April 12, 2013

16 Carboplatin, paclitaxel and sorafenib in advanced melanoma -what have we learned? Translational Cancer Research , April 3, 2013    Free full text

17 Topical treatments for chronic plaque psoriasis Cochrane Reviews, April 1, 2013

18 Topical Retinoids in Oral Lichen Planus Treatment: An Overview Dermatology, March 29, 2013    Review Article

19 Oxidative stress and psoriasis: the effect of antitumour necrosis factor- inhibitor treatment British Journal of Dermatology, April 26, 2013

20 Ingenol Mebutate Gel 0.015% and 0.05%: In Actinic Keratosis Drugs, February 1, 2013